Human-in-the-loop large language model framework for identification of cutaneous immune-related adverse events

This study evaluated a retrieval-augmented, multi-agent large language model (LLM)–driven, human-in-the-loop framework for detecting cutaneous immune-related adverse events (cirAEs) from clinical notes. Compared with the unassisted manual-review group, the LLM-assisted group demonstrated higher accuracy (F1 = 0.88 vs 0.77) and inter-rater agreement measured by Cohen’s κ ( κ = 0.82 vs 0.50), and reported an approximately one-third shorter average review time. This framework pilots how LLMs can be applied to identify immune-related toxicities and, more broadly, support accurate, scalable, and transparent adverse event data extraction.

Authors

Institutions

Publication Details

Journal
npj Precision Oncology
Published
2026-10-15
DOI
https://doi.org/10.1038/s41698-026-01737-y
Primary Topic
Pharmacovigilance and Adverse Drug Reactions
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Human-in-the-loop large language model framework for identification of cutaneous immune-related adverse events

Eudora Lee, Nicole LeBoeuf, C. Duffy, Alexander Gusev et al.
npj Precision Oncology
Pharmacovigilance and Adverse Drug Reactions
article

Human-in-the-loop large language model framework for identification of cutaneous immune-related adverse events

Eudora Lee, Nicole LeBoeuf, C. Duffy, Alexander Gusev, Lirit Fuksman, Kun‐Hsing Yu, Zeyun Lu, Ralina Karagenova, Olivia Burke, Adam Kashlan, Priya Katyal, Andrew Sedlack, Debby Cheng, Jin Ning Tian, Yevgeniy R. Semenov, Charles Lu, Chuck Lin
article en

Abstract

This study evaluated a retrieval-augmented, multi-agent large language model (LLM)–driven, human-in-the-loop framework for detecting cutaneous immune-related adverse events (cirAEs) from clinical notes. Compared with the unassisted manual-review group, the LLM-assisted group demonstrated higher accuracy (F1 = 0.88 vs 0.77) and inter-rater agreement measured by Cohen’s κ ( κ = 0.82 vs 0.50), and reported an approximately one-third shorter average review time. This framework pilots how LLMs can be applied to identify immune-related toxicities and, more broadly, support accurate, scalable, and transparent adverse event data extraction.

npj Precision Oncology
Brigham and Women's Hospital (US), The University of Texas MD Anderson Cancer Center (US), Harvard University (US), Massachusetts General Hospital (US), Dana-Farber Cancer Institute (US), Dana-Farber/Harvard Cancer Center (US)
U.S. Department of Defense, Melanoma Research Foundation, Melanoma Research Alliance, National Heart, Lung, and Blood Institute, National Institute of General Medical Sciences, National Institute of Arthritis and Musculoskeletal and Skin Diseases
Good health and well-being
Openalex Percentile: Top 43%
Pharmacovigilance and Adverse Drug Reactions
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.